Examining SpringWorks Therapeutics Inc (SWTX)’s cash flow and debt position

SpringWorks Therapeutics Inc (NASDAQ: SWTX) closed the day trading at $48.48 down -1.30% from the previous closing price of $49.12. In other words, the price has decreased by -$0.64 from its previous closing price. On the day, 1481804 shares were traded.

Ratios:

For a better understanding of SWTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.60 and its Current Ratio is at 8.60. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on February 05, 2024, initiated with a Buy rating and assigned the stock a target price of $75.

On December 01, 2022, BofA Securities started tracking the stock assigning a Buy rating and target price of $45.

H.C. Wainwright reiterated its Buy rating for the stock on January 19, 2021, while the target price for the stock was revised from $87 to $101.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 16 when Pichl Daniel sold 15,000 shares for $50.10 per share. The transaction valued at 751,550 led to the insider holds 45,212 shares of the business.

Ashar Bhavesh sold 4,834 shares of SWTX for $238,435 on Feb 05. The Chief Commercial Officer now owns 58,154 shares after completing the transaction at $49.32 per share. On Feb 02, another insider, Pichl Daniel, who serves as the Chief People Officer of the company, sold 26,181 shares for $44.32 each. As a result, the insider received 1,160,362 and left with 45,212 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SWTX now has a Market Capitalization of 3.49B and an Enterprise Value of 3.08B. Its current Enterprise Value per Revenue stands at 64.18 whereas that against EBITDA is -9.57.

Stock Price History:

Over the past 52 weeks, SWTX has reached a high of $53.78, while it has fallen to a 52-week low of $18.00. The 50-Day Moving Average of the stock is 41.36, while the 200-Day Moving Average is calculated to be 30.05.

Shares Statistics:

Over the past 3-months, SWTX traded about 1.51M shares per day on average, while over the past 10 days, SWTX traded about 1.8M shares per day. A total of 62.42M shares are outstanding, with a floating share count of 61.23M. Insiders hold about 15.03% of the company’s shares, while institutions hold 93.82% stake in the company. Shares short for SWTX as of Jan 31, 2024 were 10.41M with a Short Ratio of 6.88, compared to 11.21M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 14.44% and a Short% of Float of 17.08%.

Earnings Estimates

Current recommendations for the stock of the company come from 6 analysts. On average, analysts expect EPS of -$1.24 for the current quarter, with a high estimate of -$1.19 and a low estimate of -$1.34, while EPS last year was -$1.17. The consensus estimate for the next quarter is -$1.19, with high estimates of -$0.99 and low estimates of -$1.43.

Analysts are recommending an EPS of between -$4.28 and -$5.46 for the fiscal current year, implying an average EPS of -$4.92. EPS for the following year is -$4.6, with 8 analysts recommending between -$3.68 and -$6.

Revenue Estimates

Based on 9 analysts’ estimates, the company’s revenue will be $67.09M in the next fiscal year. The high estimate is $113.26M and the low estimate is $40.93M. The average revenue growth estimate for next year is up 7,272.50% from the average revenue estimate for this year.

Most Popular

[the_ad id="945"]